If youre considering Mounjaro or currently using it, our pharmacists can provide personalised guidance on what to expect, how to manage side effects, and when to adjust your approach
10.3389/fncel.2016.00021 217
They show that nicotine reward, tested via a conditioned place preference in mice lacking the GLP-1R, was significantly enhanced (Tuesta et al., 2012)
This drug was approved by the FDA in December 2017 and launched on the market in 2018, exclusively for the treatment of type 2 diabetes
Again, I'm not here to tell you what to do or what not to do, but if you have it in mind that peptide therapeutics, because they aren't hormone therapies, are not without their potential risks, you would be wrong